[Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
The period of survival in the group of 36 boys and 18 girls with SSPE, as well as the condition of 13 living persons were examined. 30 children were treated with isoprinosine. A 3 years-long period of survival was significantly more frequent in the group of 18 children with long-term therapy by isoprinosine in comparison to 24 children without isoprinosine administration. The best results were observed in children with subacute course of the illness and many epileptic seizures. The 13 living persons are strongly damaged. One girl is decerebrated and 5 patients are completely helpless. The indications to isoprinosine therapy in SSPE are discussed.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000627:therapeutic use*; D008297:Male; D013344:Subacute Sclerosing Panencephalitis / Q000188:drug therapy*
D007288:Inosine; D007542:Inosine Pranobex
Ocena wyników leczenia SSPE (subacute sclerosing panencephalitis) izoprynozyna.